Supplementing with the amino acid, ornithine, allows for a good night’s sleep. It can be taken regularly without harmful effects or the potential for addiction, and it helps reduce physical fatigue.*
Benefits of Ornithine:
- Reduction of occasional restlessness, anxiety and stress*
- Cleansing and detoxification *
- Nutritional support to the liver*
- Supporting the immune system.*
Ornithine is an amino acid manufactured by the body. It is produced when another amino acid, arginine, is metabolized during the production of urea, a substance found in human urine. L-ornithine is a key compound in the urea cycle, one of the body’s main processes for eliminating ammonia.
Ornithine also plays an important role in the metabolism of nitrogen and is believed by some researchers to nutritionally stimulate the natural release of growth hormones.*
Dr. Clark’s Recommendation
Dr. Clark recommended ornithine in the course of cleansing, because it degrades the ammonia in the liver released when micro organisms are killed.
She also believed that insomnia is often due to ammonia toxicity in the brain.
Results of Studies:
- Clinical studies on people hospitalized for surgery, generalized infections, trauma, or burns indicate that ornithine supplementation may support the body’s natural tendency to recover quickly from minor wounds and burns.
- A double-blind trial evaluated the effects of OKG (a form of ornithine) supplementation in elderly people recovering from acute illnesses. Those who took 10 grams of OKG per day for two months had marked improvement in appetite, weight gain, and quality of life, compared with those taking the placebo.
All Dr. Clark products undergo rigorous purity testing.
- Donati L, Ziegler F, Pongelli G, et al. Nutritional and clinical efficacy of Ornithine alpha-ketoglutarate in severe burn patients . Clin Nutr. 1999;18:307–311.
- Cynober L. place des nouveaux substrats azotés en nutrition artificielle périopératoire de l’adulte. Nutr Clin Métabole 1995;9:113 [in French].
- Brocker P, Vellas B, Albarede JL, Poynard T. A two-centre, randomized, double-blind trial of Ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing 1994;23:303–6.